Re: CALA management, unfortunately subpar 2.1
"Setting aside the management discussion, below is what's interesting about the science."
Great post, logansdad, and worthy of it's own thread.
In the future, I for one, would really appreciate if you would post anew with such information - makes it mush easier to find if backtracking. In addition to your update on the science, there are a couple of foreign studies posted to Pubmed's NCBI database revealing the current academic interest in CB-839 for its extraordinary effect on glutamine to proline conversion. Looking beyond glutaminase treatment in oncology, this research enables the potential for applications in diabetes and other metabolic disorders.